Molecular Screens for Deubiquitinase Function
Molecular Screens for Deubiquitinase Function
批准号:
6933497
负责人:
David E Sterner
金额:
$36.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-15 至 2007-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A key aspect of cellular regulation that affords a number of potential opportunities for pharmacological intervention is the maintenance of protein homeostasis. Proteins are continuously being synthesized and degraded in cells, and their cellular levels must be strictly regulated. The ubiquitin-proteasome pathway is the major non-lysosomal proteolytic system in eucaryotic cells, consisting of a multi-enzyme cascade that modifies and degrades a diverse array of proteins, including many key regulatory molecules. The modification of cellular proteins by ubiquitin (Ub) and ubiquitin-like proteins (UBL) plays an essential role in a number of biological processes, including cell cycle control, transcriptional activation, signal transduction, antigen presentation, vesicular trafficking, and intracellular proteolysis. Ubiquitination is a dynamic reversible process, with a multitude of ubiquitin ligases (E3s) and deubiquitinases (DUBs) responsible for both the wide-ranging influence of this pathway as well as its selectivity. The DUB enzymes are responsible for maintaining adequate pools of free Ub within the cell and for regulating the ubiquitination status of cellular proteins. Defects in these enzymes appear to play a role in the pathogenesis of several diseases, including Parkinson's disease, Angelman's syndrome, cervical cancer, and von Hippel Lindau syndrome. This research proposal focuses on the DUBs and on the development of a novel high-throughput assay to identify agents that modulate the activity of these key regulatory enzymes. The assay being proposed is based on the observation that certain proteins require a defined and free amino-terminal residue in order to be functional. Fusions between Ub/UBL and these proteins will serve as substrates that undergo activation upon DUB cleavage. This reaction will be optimized and adapted to a high-throughput format for eventual use in screens for inhibitors/activators of clinically relevant DUBs.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.
使用灵敏的基于酶的报告基因测定法检测和表征 SUMO 蛋白酶活性。
DOI:
10.1007/978-1-59745-566-4_18
发表时间:
2009
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Leach,CraigA, Tian,Xufan, Mattern,MichaelR, Nicholson,Benjamin]
通讯作者:
Nicholson,Benjamin
Novel TXNIP degraders for treating diabetes
-
批准号:10258437
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2021
-
负责人:David E Sterner
-
依托单位:
Ubiquitin based therapy of aggressive cancer cell populations
-
批准号:8777725
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2014
-
负责人:David E Sterner
-
依托单位:
Novel molecular therapeutics for cystic fibrosis
-
批准号:8315005
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2012
-
负责人:David E Sterner
-
依托单位:
Novel molecular therapeutics for cystic fibrosis
-
批准号:8782036
-
项目类别:
-
资助金额:$66.84万
-
财政年份:2012
-
负责人:David E Sterner
-
依托单位:
Ubiquitin E3 ligase detection by fluorescence resonance transfer
-
批准号:8848079
-
项目类别:
-
资助金额:$61.12万
-
财政年份:2012
-
负责人:David E Sterner
-
依托单位:
Ubiquitin E3 ligase detection by fluorescence resonance transfer
-
批准号:8648089
-
项目类别:
-
资助金额:$72.33万
-
财政年份:2012
-
负责人:David E Sterner
-
依托单位:
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
-
批准号:8930989
-
项目类别:
-
资助金额:$61.17万
-
财政年份:2011
-
负责人:David E Sterner
-
依托单位:
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
-
批准号:8648310
-
项目类别:
-
资助金额:$61.17万
-
财政年份:2011
-
负责人:David E Sterner
-
依托单位:
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
-
批准号:8125555
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2011
-
负责人:David E Sterner
-
依托单位:
Functional assays for osteoporosis therapeutics
-
批准号:7538083
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2008
-
负责人:David E Sterner
-
依托单位:
Molecular screen for isopeptidase inhibitors to treat pulmonary disease
-
批准号:7908583
-
项目类别:
-
资助金额:$51.71万
-
财政年份:2007
-
负责人:David E Sterner
-
依托单位:
Molecular screen for isopeptidase inhibitors to treat pulmonary disease
-
批准号:8135485
-
项目类别:
-
资助金额:$46.75万
-
财政年份:2007
-
负责人:David E Sterner
-
依托单位:
Molecular screen for isopeptidase inhibitors to treat pulmonary disease
-
批准号:7268251
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2007
-
负责人:David E Sterner
-
依托单位:
Ubiquitin ligase as a therapeutic target for arthritis
-
批准号:7051645
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2006
-
负责人:David E Sterner
-
依托单位:
YEAST TRANSCRIPTIONAL ADAPTORS IN NUCLEOSOME ACETYLATION
-
批准号:6018365
-
项目类别:
-
资助金额:$3.84万
-
财政年份:1999
-
负责人:David E Sterner
-
依托单位:
YEAST TRANSCRIPTIONAL ADAPTORS IN NUCLEOSOME ACETYLATION
-
批准号:2708555
-
项目类别:
-
资助金额:$3.02万
-
财政年份:1998
-
负责人:David E Sterner
-
依托单位: